Bioscience Animal Health PCL (BKK:BIS) Cash-to-Debt : 5.60 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bioscience Animal Health PCL Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Bioscience Animal Health PCL's cash to debt ratio for the quarter that ended in Mar. 2024 was 5.60.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Bioscience Animal Health PCL could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Bioscience Animal Health PCL's Cash-to-Debt or its related term are showing as below:

BKK:BIS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.1 Med: 3.53 Max: 31.07
Current: 5.6

During the past 7 years, Bioscience Animal Health PCL's highest Cash to Debt Ratio was 31.07. The lowest was 0.10. And the median was 3.53.

BKK:BIS's Cash-to-Debt is ranked better than
79.98% of 1858 companies
in the Consumer Packaged Goods industry
Industry Median: 0.52 vs BKK:BIS: 5.60

Bioscience Animal Health PCL Cash-to-Debt Historical Data

The historical data trend for Bioscience Animal Health PCL's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Bioscience Animal Health PCL Cash-to-Debt Chart

Bioscience Animal Health PCL Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.53

0.10

0.23

19.03

14.25

Bioscience Animal Health PCL Quarterly Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial											31.07	2.88	9.90	14.25	5.60

Competitive Comparison of Bioscience Animal Health PCL's Cash-to-Debt

For the Packaged Foods subindustry, Bioscience Animal Health PCL's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioscience Animal Health PCL's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioscience Animal Health PCL's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Bioscience Animal Health PCL's Cash-to-Debt falls into.

Bioscience Animal Health PCL Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Bioscience Animal Health PCL's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	97.614	/	(3.147	+	3.705)
	=	14.25

Bioscience Animal Health PCL's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	37.802	/	(3.333	+	3.413)
	=	5.60

Bioscience Animal Health PCL (BKK:BIS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Bioscience Animal Health PCL Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Bioscience Animal Health PCL's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioscience Animal Health PCL (BKK:BIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioscience Animal Health PCL (BKK:BIS) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bond Street Road, No. 479, 4th Floor, Muangthongthani, Bangphut, Pakkret, Nonthaburi, THA, 11120

Website

https://www.bis-group.com

Bioscience Animal Health PCL engaged in manufacture, import and distribution of pharmaceutical supplies, medical devices, equipment, and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand.